Try our Advanced Search for more refined results

Deals Rumor Mill: Frontier-Suzhou, VF Corp., SIG Combibloc

By Adam Rhodes (August 10, 2018, 8:35 PM EDT) -- A pair of Chinese drug developers are looking to join in on a growing trend of biotech public offerings in Hong Kong, Bloomberg reported on Friday. Citing anonymous sources, it said the drug developers, Frontier Biotechnologies and Suzhou Kintor Pharmaceuticals Inc., are looking to go public in listings that could each bring in around $300 million. According to the report, there has been a wave biotech listing in Hong Kong thanks to new regulations in the city, which the outlet said let unprofitable biotechs publicly list....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!